Sandbox reserved 1651

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 22: Line 22:
The cis-PT catalyze the chain elongation of FPP by successive head-to-tail condensation with a specific number of IPP to form linear lipids with designated chain lengths. The reaction is as follows:
The cis-PT catalyze the chain elongation of FPP by successive head-to-tail condensation with a specific number of IPP to form linear lipids with designated chain lengths. The reaction is as follows:
IPP headgroups are bound to the enzyme at the superficial polar region while the carbon chains point toward the deep hydrophobic tunnel. First, the pyrophosphate group (FPP) of the initiatory substrate, which interacts with a Mg<sup>2+</sup> ion, is hydrolyzed at the S1 site. Then, the condensation of remaining carbon with the IPP from S2 site follows. The elongated products translocate to the S1 so the carbon chain goes into the hydrophobic tunnel of the active site. At the end, a new IPP molecule binds to the S2 site and the cycle is repeated until the active site can no longer accommodate the long chain isoprenoid.
IPP headgroups are bound to the enzyme at the superficial polar region while the carbon chains point toward the deep hydrophobic tunnel. First, the pyrophosphate group (FPP) of the initiatory substrate, which interacts with a Mg<sup>2+</sup> ion, is hydrolyzed at the S1 site. Then, the condensation of remaining carbon with the IPP from S2 site follows. The elongated products translocate to the S1 so the carbon chain goes into the hydrophobic tunnel of the active site. At the end, a new IPP molecule binds to the S2 site and the cycle is repeated until the active site can no longer accommodate the long chain isoprenoid.
- 
=== Regulation of the product length ===
=== Regulation of the product length ===
Line 46: Line 45:
== References ==
== References ==
<references/>
<references/>
 +
 +
Michal Lisnyansky Bar-El et al. Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complex. ''Nature Communications''. '''11''':523, (2020).

Revision as of 22:43, 13 January 2021

Heterotetrameric Cis-Prenyltransferase Complex

Caption for this structure

Drag the structure with the mouse to rotate

References


Michal Lisnyansky Bar-El et al. Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complex. Nature Communications. 11:523, (2020).

Personal tools